TABLE 2.
Association of CENP-A expression with the clinicopathological characteristics of patients with glioma (logistic regression).
| Characteristics | Total (n) | Odds ratio (OR) | p-value |
|---|---|---|---|
| WHO grade (G4 vs. G2 and G3) | 635 | 49.884 (23.515–129.060) | <0.001 |
| Primary therapy outcome (PD and SD vs. PR and CR) | 462 | 2.444 (1.641–3.675) | <0.001 |
| IDH status (WT vs. Mut) | 686 | 13.760 (9.247–20.963) | <0.001 |
| 1p/19q co-deletion (no co-deletion vs. co-deletion) | 689 | 5.910 (3.947–9.061) | <0.001 |
| Age (>60 vs. ≤60) | 696 | 4.024 (2.678–6.175) | <0.001 |
| Gender (Male vs. Female) | 696 | 1.098 (0.813–1.484) | 0.540 |
WHO, world health organization; IDH, isocitrate dehydrogenase; WT, wild-type; MUT, mutated; PD, progressive disease; SD, stable disease; PR, partial response; CR, complete response.